Protect Pharmaceutical Corp. (PRTT)
0.25
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Protect Pharmaceutical EPS Diluted (Quarterly) : -0.0004 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0004 |
| March 31, 2026 | 0.00 |
| June 30, 2025 | 0.0012 |
| March 31, 2025 | 0.1142 |
| December 31, 2024 | 0.175 |
| September 30, 2024 | 0.4542 |
| June 30, 2024 | 0.2346 |
| March 31, 2024 | 0.1166 |
| December 31, 2023 | 0.2465 |
| September 30, 2023 | 0.4036 |
| June 30, 2023 | 0.0113 |
| March 31, 2023 | 0.1377 |
| March 31, 2022 | 0.0988 |
| December 31, 2021 | 0.00 |
| June 30, 2021 | 0.0034 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.0002 |
| September 30, 2020 | 0.0105 |
| June 30, 2020 | 0.0951 |
| March 31, 2020 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| June 30, 2018 | -0.004 |
| March 31, 2018 | -0.0034 |
| December 31, 2017 | -0.0035 |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0027 |
| June 30, 2017 | -0.0903 |
| March 31, 2017 | -0.01 |
| December 31, 2016 | -0.02 |
| September 30, 2016 | -0.01 |
| June 30, 2016 | -0.0094 |
| March 31, 2016 | -0.0033 |
| December 31, 2015 | -0.0059 |
| September 30, 2015 | -1.43 |
| June 30, 2015 | -0.07 |
| March 31, 2015 | -0.05 |
| December 31, 2014 | 5.340 |
| September 30, 2014 | -0.13 |
| June 30, 2014 | -0.23 |
| March 31, 2014 | -0.05 |
| December 31, 2013 | -0.09 |
| September 30, 2013 | -0.12 |
| June 30, 2013 | -0.25 |
| March 31, 2013 | -0.07 |
| December 31, 2012 | -0.19 |
| September 30, 2012 | -2.76 |
| June 30, 2012 | -4.29 |
| December 31, 2011 | -0.01 |
| September 30, 2011 | -0.01 |
| June 30, 2011 | -10.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IGC Pharma, Inc. | -0.0293 |
| Cryoport, Inc. | -0.2033 |
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| GB Sciences, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.02M |
| Total Expenses (Quarterly) | 0.02M |
| Enterprise Value | 14.37M |
| Earnings Yield | 46.00% |
| Normalized Earnings Yield | 46.00 |